Trade Pfizer ^PFE

Meningococcal Vaccines Market Size to Surpass $9.05 Billion, Globally, by 2032 at 10.4% CAGR: Coherent Market Insights

Pfizer Inc. (PFE): One of the Safe Dividend Stocks with Yields Above 5%

Creegan & Nassoura Financial Group LLC Sells 925 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer (PFE) Price Target Reduced by BofA, Neutral Outlook Maintained | PFE Stock News

Ossiam Boosts Stock Holdings in Pfizer Inc. (NYSE:PFE)

Capital International Inc. CA Raises Holdings in Pfizer Inc. (NYSE:PFE)

Capital World Investors Reduces Stock Position in Pfizer Inc. (NYSE:PFE)

Epoch Investment Partners Inc. Decreases Position in Pfizer Inc. (NYSE:PFE)

GeoWealth Management LLC Trims Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Position Reduced by Mirova

Manufacturing Stocks To Research - April 19th

Coastline Trust Co Sells 1,500 Shares of Pfizer Inc. (NYSE:PFE)

Natixis Raises Stake in Pfizer Inc. (NYSE:PFE) | MarketBeat

Norinchukin Bank The Has $6.75 Million Position in Pfizer Inc. (NYSE:PFE)

Claret Asset Management Corp Grows Stock Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Sold by Dimensional Fund Advisors LP

Israel''s healthcare at the forefront using AI

Pfizer (PFE) Faces Activist Pressure from Starboard Value

Pfizer Inc. (PFE): Among Jeff Smith's Top Activist Targets

Pfizer (NYSE:PFE) Trading 0.4% Higher - Still a Buy?

BI Asset Management Fondsmaeglerselskab A S Lowers Stock Holdings in Pfizer Inc. (NYSE:PFE)

Commerce Bank Decreases Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Sold by Cadence Bank

Capital International Sarl Buys 12,495 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer faces legal backlash: Texas, Kansas, and more states begin to challenge Prep Act Immunity Shield - NaturalNews.com

Capital International Ltd. CA Increases Stock Position in Pfizer Inc. (NYSE:PFE)

Dean Investment Associates LLC Has $2.57 Million Stock Position in Pfizer Inc. (NYSE:PFE)

Arrow Capital Pty Ltd Invests $3.98 Million in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Sold by Insigneo Advisory Services LLC

Bridgewater Associates LP Grows Stock Position in Pfizer Inc. (NYSE:PFE)

Branded Generics Market Size, Share, Trends, Opportunity, and Forecast, 2020-2024 & 2025-2030F | Valuespectrum.com

Antibody-drug Conjugates Innovations Research Report 2025: $227 Billion in Deals Signal ADC Market Boom - Pfizer and Daiichi Sankyo Emerge as Leading Trial Sponsors | Valuespectrum.com

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors | The Manila Times

Truly Novel RA Drug Passes Mid-Stage Test | MedPage Today

Is Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits?

Eli Lilly shares surge on new obesity pill data. What it means for the stock from here

CDC Advisory Boosts Pfizer (PFE) Vaccine Prospects

Viking Therapeutics (VKTX) Shares Surge on Pfizer's Decision

Arrow Capital Pty Ltd Buys New Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Bought by CANADA LIFE ASSURANCE Co

34,100 Shares in Pfizer Inc. (NYSE:PFE) Acquired by MSH Capital Advisors LLC

Zacks Investment Management Buys 46,982 Shares of Pfizer Inc. (NYSE:PFE)

Marshall Wace LLP Lowers Stock Holdings in Pfizer Inc. (NYSE:PFE)

NFJ Investment Group LLC Acquires 404,266 Shares of Pfizer Inc. (NYSE:PFE)

Gamco Investors INC. ET AL Grows Stake in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Bought by Gabelli Funds LLC

Manufacturing Stocks To Add to Your Watchlist - April 14th

US CDC advisers weigh lower age recommendation for RSV vaccines

Hemophilia B Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | UniQure Biopharma B.V., CSL Behring, Pfizer/Spark Therapeutics, Genzyme Sanofi | ABNewswire

Pfizer: Danuglipron development for a pill alternative to Ozempic canned after liver side effects recorded

Pfizer (PFE) Sees Expanded Recommendation for RSV Vaccine

CDC Panel Backs Pfizer's (PFE) RSV Vaccine for At-Risk Adults Aged 50-59 | PFE Stock News

Pharmaceutical firms 'may have to divert €100bn investment from Europe to US'

Pfizer (NYSE:PFE) Shares Down 0.4% - Should You Sell?

Pfizer (NYSE:PFE) Trading 2% Higher - Here's Why

Finward Bancorp Purchases New Position in Pfizer Inc. (NYSE:PFE)

Ontario Teachers Pension Plan Board Buys 23,771 Shares of Pfizer Inc. (NYSE:PFE)

Rep. Carol D. Miller Sells Pfizer Inc. (NYSE:PFE) Shares

What You Need to Know Ahead of Pfizer's Earnings Release

M Holdings Securities Inc. Invests $2.14 Million in Pfizer Inc. (NYSE:PFE)

Guggenheim Capital LLC Sells 75,970 Shares of Pfizer Inc. (NYSE:PFE)

Mariner LLC Has $40.56 Million Stock Position in Pfizer Inc. (NYSE:PFE)

Pfizer (PFE) Stock Moves Despite Drug Development Halt

Pfizer Inc (PFE) in FPA Queens Road Value Fund Q2 2024

Pfizer (NYSE:PFE) Trading 1.2% Higher - Here's What Happened

Bladder Cancer Advocacy Network Announces National Presenting Sponsorships by Ferring Pharmaceuticals and the Astellas/Pfizer Alliance for the 2025 Walks to End Bladder Cancer | Morningstar

Pfizer Inc. (NYSE:PFE) Shares Purchased by Schwerin Boyle Capital Management Inc.

Pfizer on Pace for Largest Percent Increase Since December 2024 - Data Talk | Morningstar

Haleon Takes Full Control Of Chinese Consumer Healthcare Venture

8,784 Shares in Pfizer Inc. (NYSE:PFE) Bought by Rossby Financial LCC

Pfizer Inc. (NYSE:PFE) Stock Position Lifted by XTX Topco Ltd

Pfizer Inc. (NYSE:PFE) Position Boosted by CreativeOne Wealth LLC

Pfizer Inc. (NYSE:PFE) Stake Boosted by CreativeOne Wealth LLC

Pfizer (PFE) Abandons Obesity Drug Trial Due to Safety Concerns

Pfizer (PFE) Halts Trial of GLP-1 Pill Due to Safety Concerns

Why Pfizer scrapped obesity pill development: Weight-loss drug market - Healthcare News | The Financial Express

Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation

Counterfeit Ozempic in U.S. Drug Supply; Oral GLP-1 Axed; Food Additives and T2D | MedPage Today

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

Pharmaceutical Stocks To Add to Your Watchlist - April 14th

Pfizer halts development of weight loss pill after liver injury report

Pfizer: Discontinuation of Obesity Drug Candidate Danuglipron Has No Effect on Our Valuation | Morningstar

Pfizer Discontinues Development of Oral GLP-1 Receptor Agonist Danuglipron

10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

Wegovy, Zepbound makers' stocks rally as a weight-loss-drug competitor drops out | Morningstar

Pfizer's Obesity Setback Puts Pressure on CEO to Make a Deal

U.S. Stocks Close: Tech Tariffs Temporarily Suspended, Three Major Indices Rise Collectively, Chinese Stocks Gain Broadly | SMM

Pfizer Inc. (PFE): "Dead Money… Close the Casket," Says Jim Cramer

Invion: Revolutionizing Photodynamic Therapy (PDT) for Cancer, Infectious Diseases | INN

Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback

Broyhill Asset Management Makes New $231,000 Investment in Pfizer Inc. (NYSE:PFE)

Viking Therapeutics (VKTX) Gains Attention After Pfizer's Setback | PFE Stock News

Pfizer (PFE) Exits GLP-1 Race: Impact on Eli Lilly, Novo Nordisk, and Viking Therapeutics

Pfizer (PFE) Halts Obesity Drug Development Amid Safety Concerns | PFE Stock News

Viking Therapeutics (VKTX) Shares Surge After Pfizer's Danuglipron Halt | GPCR Stock News

Pfizer's (PFE) Halt on Drug Boosts Prospects for Structure Therapeutics (GPCR) | GPCR Stock News

Pfizer will stop development of daily weight-loss pill danuglipron | Fox Business

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Gold Price Today: XAU/USD Over $3,350 on Trump's Tariff Policies Uncertainty

Morning Note: Dollar Falls on Trump-Fed Fears; Japan in US Trade Talks; China holds rates

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Stock market today: Nifty above 24,400, Sensex up 309 points

Morning Note: Fed Cautious on Tariffs; US-Japan Currency Tensions; Oil Up

Morning Note: UK Inflation Data, US Retail Sales Loom, BoC Rate Expected to Hold